Evaluating Engineered CD4 and CD8 T Cells in the Treatment of Advanced PDA 2025 Partnership with the Alliance for Cancer Gene Therapy Philip Greenberg, MD, Fred Hutchinson Cancer Research Center Read More
EGFR-Positive Lung Cancer: Treatment-Induced Mutagenesis, Exon-20, and Strategies to Delay Relapses 2025 Partnership with the Israel Cancer Research Fund Yosef Yarden, PhD, Weizmann Institute of Science Read More
KDM3B as a Genotype-Specific Target in IDH1/2-Mutant Clonal Hematopoiesis and Leukemia 2025 Momentum Fellow Hannah Fay Read More
Investigating the Mechanisms Through Which Gliomas Integrate into Neuronal Circuitries 2025 Momentum Fellow Alessandro Matera, PhD Read More
Integrating Multiomics Data to Characterize Lung Cancer and Tumor Microenvironment 2025 Momentum Fellow Oriol Pich, MD, PhD Read More
Precision Therapy for Treating Li-Fraumeni Syndrome: Can Rezatapopt Delay or Prevent Tumorigenesis in Mice with a Germline TP53-Y220C Mutation? ASPIRE Award Gerard Zambetti, PhD, St. Jude Children's Research Hospital Read More
Spatio-temporal Quantification of Tumor-Immune Interactions in Colorectal Cancer as a Determinant of Organotropism Cancer Research Institute-Mark Foundation Immuno-Informatics Postdoctoral Fellow Maryam Pourmaleki, PhD, Stanford University Read More
Time-Resolved Evolution of the Metastatic Immune Environment in Colorectal Cancer ASPIRE Award in Partnership with Contra el Cáncer Investigación (Spanish Association Against Cancer) Eduard Batlle, PhD, Institute for Research in Biomedicine (IRB Barcelona); Ido Amit, PhD, Weizmann Institute of Science; Holger Heyn, PhD, Centro Nacional de Análisis Genómico (CNAG) Read More
Deciphering the Tumor Microenvironment Mechanisms Driving Tissue-Resident vs. Circulating CD8 T Cell Dysfunction and Antitumor Responses in Human Cancer EACR-Mark Foundation Postdoctoral Fellow Christina Metoikidou, PhD, Netherlands Cancer Institute and the Oncode Institute Read More
